Recent Updates
Recently added Catalysts
MOBI Positive Sentiment

Mobia Medical to Report Third Quarter 2026 Financial Results on November 5, 2026

Key Takeaway: Mobia Medical, Inc. will report its third quarter 2026 financial results on November 5, 2026. The company is known for its innovative Vivistim® Paired VNS™ System, which aids stroke recovery. A conference call and webcast will follow the financial report to discuss results and provide updates.

Market Sentiment Analysis

POSITIVE FACTORS

  • Mobia Medical is redefining stroke recovery.
  • The Vivistim® Paired VNS™ System is FDA-approved.
  • The company is actively engaging with investors.

Full Press Release Details

AUSTIN, Texas, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that the Company will report third quarter 2026 financial results on Thursday, November 5, 2026. Mobia Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

Conference Call and Webcast Details

Those interested in listening to the conference call should register online using this link. Once registered, participants will receive dial-in numbers and a unique PIN to join the call. Participants are encouraged to register more than 15 minutes prior to the start of the call. A live and archived webcast can also be accessed via the News & Events page of the investor section of Mobia Medical’s website.

About Mobia Medical, Inc.

Mobia Medical, Inc. is a medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The Company’s Vivistim® Paired VNS™ System is the first and only clinically validated, FDA-approved implantable solution designed to improve upper limb function in chronic ischemic stroke survivors with moderate to severe upper extremity impairments. Therapy with the Vivistim® Paired VNS™ System combines targeted vagus nerve stimulation with functional movement to promote neuroplasticity and drive meaningful improvements in motor function. Mobia Medical is mobilizing patients, providers, and care partners to establish a better way forward in stroke care.

Investor Relations Contact Louisa Smith Gilmartin Group, LLC investors@mobia.com

Frequently Asked Questions

When will Mobia Medical report its financial results?

Mobia Medical will report its third quarter 2026 financial results on November 5, 2026.

What is the Vivistim® Paired VNS™ System?

The Vivistim® Paired VNS™ System is an FDA-approved solution for improving upper limb function in stroke survivors.

How can I join the Mobia Medical conference call?

Participants can register online to receive dial-in numbers and a unique PIN for the conference call.

What time is the Mobia Medical conference call?

The conference call will take place at 4:30 p.m. ET on November 5, 2026.

Last updated: Oct 15, 2026